PIMA541722
Ranibizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541722-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541722 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Ranibizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
Fab-12 variant Y0317; Lucentis; RhuFab
Immunogen
Human VEGFA
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
1.89 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein L
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 F(ab) κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO)
- It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment
- Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity.
Compare Similar Items
Show Difference
Antigen: Ranibizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: Fab-12 variant Y0317; Lucentis; RhuFab
Immunogen: Human VEGFA
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.89 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein L
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 F(ab) κ
Antigen:
Ranibizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
Fab-12 variant Y0317; Lucentis; RhuFab
Immunogen:
Human VEGFA
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.89 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein L
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 F(ab) κ
Antigen: Pascolizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: SB-240683
Immunogen: Human IL4
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.15 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Pascolizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
SB-240683
Immunogen:
Human IL4
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.15 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Foravirumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CR4098; RV
Immunogen: Rabies virus RV
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Foravirumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CR4098; RV
Immunogen:
Rabies virus RV
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Rafivirumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CR57; RV
Immunogen: Rabies virus RV
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.23 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 λ
Antigen:
Rafivirumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CR57; RV
Immunogen:
Rabies virus RV
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.23 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 λ